These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10797551)

  • 21. Late-onset Huntington disease with intermediate CAG repeats: true or false?
    Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic membrane transporters.
    Boon JM; Smith BD
    Curr Opin Chem Biol; 2002 Dec; 6(6):749-56. PubMed ID: 12470727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis.
    Seixas AI; Holmes SE; Takeshima H; Pavlovich A; Sachs N; Pruitt JL; Silveira I; Ross CA; Margolis RL; Rudnicki DD
    Ann Neurol; 2012 Feb; 71(2):245-57. PubMed ID: 22367996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.
    Cooper AJ; Sheu KF; Burke JR; Strittmatter WJ; Gentile V; Peluso G; Blass JP
    J Neurochem; 1999 Mar; 72(3):889-99. PubMed ID: 10037459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Expansion of CAG, CAA, and Mixed CAG/CAA Repeats.
    Figura G; Koscianska E; Krzyzosiak WJ
    Int J Mol Sci; 2015 Aug; 16(8):18741-51. PubMed ID: 26270660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of synthetic ion channels is influenced by cation-pi interactions with phospholipid headgroups.
    Weber ME; Elliott EK; Gokel GW
    Org Biomol Chem; 2006 Jan; 4(1):83-9. PubMed ID: 16358000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.
    Tanaka M; Machida Y; Nukina N
    J Mol Med (Berl); 2005 May; 83(5):343-52. PubMed ID: 15759103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversity of amyloid beta protein fragment [1-40]-formed channels.
    Kourie JI; Henry CL; Farrelly P
    Cell Mol Neurobiol; 2001 Jun; 21(3):255-84. PubMed ID: 11569537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling the polyglutamine aggregation pathway in Huntington's disease: from basic studies to clinical applications.
    Sugaya K
    Subcell Biochem; 2012; 65():353-88. PubMed ID: 23225011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.
    Zhang X; Abels ER; Redzic JS; Margulis J; Finkbeiner S; Breakefield XO
    Cell Mol Neurobiol; 2016 Apr; 36(3):459-70. PubMed ID: 26951563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lepidopteran-specific crystal toxins from Bacillus thuringiensis form cation- and anion-selective channels in planar lipid bilayers.
    Schwartz JL; Garneau L; Savaria D; Masson L; Brousseau R; Rousseau E
    J Membr Biol; 1993 Feb; 132(1):53-62. PubMed ID: 7681482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct alteration of the P/Q-type Ca2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6.
    Matsuyama Z; Wakamori M; Mori Y; Kawakami H; Nakamura S; Imoto K
    J Neurosci; 1999 Jun; 19(12):RC14. PubMed ID: 10366652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal electrical properties of hippocampal neurons modelling early Huntington disease pathogenesis.
    Shelbourne P; Coote E; Dadak S; Cobb SR
    Brain Res; 2007 Mar; 1139():226-34. PubMed ID: 17291464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.
    Chen S; Berthelier V; Yang W; Wetzel R
    J Mol Biol; 2001 Aug; 311(1):173-82. PubMed ID: 11469866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.
    Ross CA
    Neuron; 2002 Aug; 35(5):819-22. PubMed ID: 12372277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method for the incremental expansion of polyglutamine repeats in recombinant proteins.
    Robertson AL; Bottomley SP
    Methods Mol Biol; 2013; 1017():73-83. PubMed ID: 23719908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of ion channels in planar lipid bilayer membranes by synthetic basic peptides.
    Anzai K; Hamasuna M; Kadono H; Lee S; Aoyagi H; Kirino Y
    Biochim Biophys Acta; 1991 May; 1064(2):256-66. PubMed ID: 1709812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magainin 2 channel formation in planar lipid membranes: the role of lipid polar groups and ergosterol.
    Gallucci E; Meleleo D; Micelli S; Picciarelli V
    Eur Biophys J; 2003 Mar; 32(1):22-32. PubMed ID: 12632203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of alpha 1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6.
    Piedras-Renteria ES; Watase K; Harata N; Zhuchenko O; Zoghbi HY; Lee CC; Tsien RW
    J Neurosci; 2001 Dec; 21(23):9185-93. PubMed ID: 11717352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.